http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010514820-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate | 2008-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010514820-A |
| titleOfInvention | Novel 2,4-dianilinopyrimidines, their preparation as drugs, pharmaceutical compositions and their use as essentially IKK inhibitors |
| abstract | The present invention relates to a product of formula (I) Wherein, R2, one of R3 and R4 is Hal or CF 3, the other two H, be Hal or one or more alkyl and alkoxy optionally substituted by Hal; R1 is H, Cycloalkyl, alkyl, alkenyl, or alkynyl, all optionally substituted; A is a single bond or —CH 2 —CO—NR 6 —, Rβ is selected from the meaning of R 1; (Y)) is monocyclic or bicyclic containing 4 to 10 bonds, Y is O, S, SO, SO2, N-R7 (ring (Y) may include a carbon bridge), C═O or dioxolane thereof, CF 2, CH—OR 8, CH—NR 8 R 9; R 7 is hydrogen, cycloalkyl, alkyl, CH 2 -alkenyl or CH 2 -alkynyl (optionally substituted) By and; R8 is hydrogen, alkyl, (optionally substituted) cycloalkyl or heterocycloalkyl. The present invention basically relates to all isomers of said products and their salts as medicaments used as IKK inhibitors. |
| priorityDate | 2007-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 352.